PDEX
Pro-Dex, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$54.66-4.74%
Price as of Jul 20, 2026
PDEX growth
Pro-Dex, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +16.4%
- EBITDA
- +41.4%
- EBIT
- -7.6%
- EPS
- +29.4%
- Free cash flow
- +498.5%
- Operating cash flow
- +1601.4%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +16.6%
- EBITDA
- +27.1%
- EBIT
- +27.8%
- Net income
- +25.2%
- EPS
- +29.4%
- Free cash flow
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.